News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Newsfile Corp
NEWS
IN THE PRESS
Press Releases
Hemostemix Granted Trademark “KNOW YOUR HEALTH” in Japan, International Registration No. 1744775 Covers Stem Cell Preparations and Research in Classes 1, 5, 42
October 22, 2025
·
9 min read
Press Releases
OS Therapies Announces Overall and Event Free Survival Key Subgroup Data for OST-HER2 in Recurrent, Fully Resected, Pulmonary Metastatic Osteosarcoma
October 22, 2025
·
5 min read
Press Releases
Optimi Health Provides Corporate Update
October 21, 2025
·
5 min read
Press Releases
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
October 21, 2025
·
4 min read
Press Releases
Adaptimmune Announces Delisting from Nasdaq
October 20, 2025
·
6 min read
Press Releases
PreveCeutical Provides Update on Plan of Arrangement with BioGene Therapeutics Inc.
October 20, 2025
·
5 min read
Press Releases
Sona Nanotech Reports 80% Response Rate in First-In-Human THT Cancer Therapy Study
October 20, 2025
·
6 min read
Press Releases
Cardiol Therapeutics Secures US$11 Million Financing and Extends Cash Runway into Q3 2027
October 17, 2025
·
7 min read
Press Releases
Sona Nanotech To Host Investor Webinar To Discuss Clinical Study
October 17, 2025
·
2 min read
Press Releases
PharmaTher Applauds FDA’s Commissioner’s National Priority Voucher (CNPV) Selection of Ketamine; Company Highlights Potential Ketamine Opportunity, 505(b)(2) Focus, and Upside from Strategic ANDA Sale
October 17, 2025
·
8 min read
15 Toronto St., Suite 601 Toronto ON M5C 2E3 US
Tel: 416-806-1750
Visit website
Email Us